control aav9 scrna (Vigene Biosciences)
86
Structured Review
Vigene Biosciences
control aav9 scrna
Control Aav9 Scrna, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/controller/aav8/pmc13054580-50-19-21
Average 86 stars, based on 1 article reviews
Control Aav9 Scrna, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/controller/aav8/pmc13054580-50-19-21
Average 86 stars, based on 1 article reviews
control aav9 scrna - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Bioprocessing:Article Title: Artificial expression constructs for selectively modulating gene expression in non-neuronal brain cells Article Snippet: .. For example, Vigene Biosciences provides AAV products including Knockdown:Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: .. For the myocardial knockdown of PTEN-L or Parkin , male C57BL/6 J mice were injected with AAV9-cTnT-shPTEN-L, AAV9-cTnT-shParkin, or Injection:Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: .. For the myocardial knockdown of PTEN-L or Parkin , male C57BL/6 J mice were injected with AAV9-cTnT-shPTEN-L, AAV9-cTnT-shParkin, or Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: Tamoxifen [20 mg/(kg·d); T-5648, Sigma, MO, USA] was administered intraperitoneally to 6-week-old male mice for 5 consecutive days to induce Cre-mediated recombination. .. To induce cardiac-specific USP18 overexpression, male C57BL/6 J mice received a single tail vein injection of Control:Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: .. For the myocardial knockdown of PTEN-L or Parkin , male C57BL/6 J mice were injected with AAV9-cTnT-shPTEN-L, AAV9-cTnT-shParkin, or Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: Tamoxifen [20 mg/(kg·d); T-5648, Sigma, MO, USA] was administered intraperitoneally to 6-week-old male mice for 5 consecutive days to induce Cre-mediated recombination. .. To induce cardiac-specific USP18 overexpression, male C57BL/6 J mice received a single tail vein injection of Isolation:Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: .. NRVMs were isolated by enzymatic digestion of 1–3-day-old rat hearts, followed by pre-plating to remove nonmyocytes and collection of the enriched cardiomyocyte population following the method described by Liu et al . . Over Expression:Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: Tamoxifen [20 mg/(kg·d); T-5648, Sigma, MO, USA] was administered intraperitoneally to 6-week-old male mice for 5 consecutive days to induce Cre-mediated recombination. .. To induce cardiac-specific USP18 overexpression, male C57BL/6 J mice received a single tail vein injection of Virus:Article Title: USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L Article Snippet: Tamoxifen [20 mg/(kg·d); T-5648, Sigma, MO, USA] was administered intraperitoneally to 6-week-old male mice for 5 consecutive days to induce Cre-mediated recombination. .. To induce cardiac-specific USP18 overexpression, male C57BL/6 J mice received a single tail vein injection of |